« Back
Home /
Recombinant Human VCAM1/CD106 His

Recombinant Human VCAM1/CD106 His

Manufacturer	Cell Sciences
Category	Oncology Neuroscience Neuroinflammation Molecular Targets for Neuroscience Targets for Rodent Neurosciences Neural Signaling Neural Adhesion Molecules By Cell Type Blastoma Carcinoma Hematology Myeloma Sarcoma Peptides & Proteins Recombinant Proteins Cell Biology Cell Movement Cell Adhesion By Organ Lung Cancer
Type	Proteins
Specific against	Human
Amount	10 ug
Host	E.coli
Item no.	CS-CRV104B
Targets	VCAM1, NCAM1
Conjugate/Tag	His
eClass 6.1	34160400
eClass 9.0	42020190
Available
Description	VCAM1 is a member of the Ig superfamily. It is a cell surface sialoglycoprotein expressed by cytokine activated endothelium. VCAM-1 contains 6 or 7 immunoglobulin domains, and is expressed on both large and small vessels only after the endothelial cells are stimulated by cytokines. The protein has a number of functions including the regulation of leukocyte migration, leukocyte endothelial cell adhesion and signal transduction and may play a role in a number of inflammatory diseases (artherosclerosis and rheumatoid arthritis). VCAM1 Human Recombinant is expressed in, E. coli, containing 674 amino acids (a.a. 25-698) fused to an amino terminal hexahistidine tag, having a total MW of 78.8kDa.
Endotoxin Level	< 0.1 ng/ug VCAM1
Formulation	Liquid in 10 mM Tris-HCl, pH 8 + 250 mM NaCl + 0.5 mM DTT + 1.5 mM cysteine + 50% glycerol
Storage and Stability	Stable for 2 weeks at 2-4C or in working aliquots at -20C for longer storage. Avoid repeated freeze-thaw cycles.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.